[
  {
    "pdf_id": "670",
    "page_number": 1,
    "block_id": "670_p1_b001",
    "text": "Members of Congress Question FDA Proposal Designed to Create Liability Shield for Drug and Device Co",
    "bbox": [
      45.3,
      11.0,
      596.7,
      27.6
    ],
    "font_size": 11.0,
    "font_name": "FreeSansBold",
    "label": "HH1"
  },
  {
    "pdf_id": "670",
    "page_number": 1,
    "block_id": "670_p1_b002",
    "text": "Today Representatives Henry A. Waxman, John D. Dingell, Frank Pallone, Jr., Rosa L.",
    "bbox": [
      42.8,
      103.9,
      503.6,
      123.1
    ],
    "font_size": 12.0,
    "font_name": "FreeSans",
    "label": "BODY"
  },
  {
    "pdf_id": "670",
    "page_number": 1,
    "block_id": "670_p1_b003",
    "text": "DeLauro, and Edward Markey, and Senators Edward M. Kennedy, Patrick J. Leahy, and",
    "bbox": [
      42.8,
      118.9,
      510.4,
      138.1
    ],
    "font_size": 12.0,
    "font_name": "FreeSans",
    "label": "BODY"
  },
  {
    "pdf_id": "670",
    "page_number": 1,
    "block_id": "670_p1_b004",
    "text": "Christopher J. Dodd, questioned the basis for a new Food and Drug Administration (FDA)",
    "bbox": [
      42.8,
      133.9,
      517.0,
      153.1
    ],
    "font_size": 12.0,
    "font_name": "FreeSans",
    "label": "BODY"
  },
  {
    "pdf_id": "670",
    "page_number": 1,
    "block_id": "670_p1_b005",
    "text": "proposal that was apparently designed to shield pharmaceutical and device companies from",
    "bbox": [
      42.8,
      148.9,
      531.0,
      168.1
    ],
    "font_size": 12.0,
    "font_name": "FreeSans",
    "label": "BODY"
  },
  {
    "pdf_id": "670",
    "page_number": 1,
    "block_id": "670_p1_b006",
    "text": "liability for injuries sustained by American consumers as a result of unsafe products.",
    "bbox": [
      42.8,
      163.9,
      488.3,
      183.1
    ],
    "font_size": 12.0,
    "font_name": "FreeSans",
    "label": "BODY"
  },
  {
    "pdf_id": "670",
    "page_number": 1,
    "block_id": "670_p1_b007",
    "text": "“We are concerned that the intent of this proposal is to protect companies in the pharmaceutical",
    "bbox": [
      42.8,
      223.9,
      549.7,
      243.1
    ],
    "font_size": 12.0,
    "font_name": "FreeSans",
    "label": "BODY"
  },
  {
    "pdf_id": "670",
    "page_number": 1,
    "block_id": "670_p1_b008",
    "text": "and device industry from being held liable for marketing products they know are unsafe,” said",
    "bbox": [
      42.8,
      238.9,
      536.3,
      258.1
    ],
    "font_size": 12.0,
    "font_name": "FreeSans",
    "label": "BODY"
  },
  {
    "pdf_id": "670",
    "page_number": 1,
    "block_id": "670_p1_b009",
    "text": "the members in a letter to FDA Commissioner von Eschenbach. “Such a policy change comes",
    "bbox": [
      42.8,
      253.9,
      541.7,
      273.1
    ],
    "font_size": 12.0,
    "font_name": "FreeSans",
    "label": "BODY"
  },
  {
    "pdf_id": "670",
    "page_number": 1,
    "block_id": "670_p1_b010",
    "text": "at the expense of consumers and violates the mission of the FDA.”",
    "bbox": [
      42.8,
      268.9,
      396.3,
      288.1
    ],
    "font_size": 12.0,
    "font_name": "FreeSans",
    "label": "BODY"
  },
  {
    "pdf_id": "670",
    "page_number": 1,
    "block_id": "670_p1_b011",
    "text": "FDA’s proposed rule would amend the regulations that permit companies to promptly update",
    "bbox": [
      42.8,
      328.9,
      533.0,
      348.1
    ],
    "font_size": 12.0,
    "font_name": "FreeSans",
    "label": "BODY"
  },
  {
    "pdf_id": "670",
    "page_number": 1,
    "block_id": "670_p1_b012",
    "text": "their drug and device labels with new safety information without waiting for FDA approval.",
    "bbox": [
      42.8,
      343.9,
      520.3,
      363.1
    ],
    "font_size": 12.0,
    "font_name": "FreeSans",
    "label": "BODY"
  },
  {
    "pdf_id": "670",
    "page_number": 1,
    "block_id": "670_p1_b013",
    "text": "These regulations serve the vitally important public health function of ensuring that patients and",
    "bbox": [
      42.8,
      358.9,
      548.4,
      378.1
    ],
    "font_size": 12.0,
    "font_name": "FreeSans",
    "label": "BODY"
  },
  {
    "pdf_id": "670",
    "page_number": 1,
    "block_id": "670_p1_b014",
    "text": "healthcare providers are made aware of safety risks associated with their medical products at",
    "bbox": [
      42.8,
      373.9,
      537.7,
      393.1
    ],
    "font_size": 12.0,
    "font_name": "FreeSans",
    "label": "BODY"
  },
  {
    "pdf_id": "670",
    "page_number": 1,
    "block_id": "670_p1_b015",
    "text": "the earliest possible moment.",
    "bbox": [
      42.8,
      388.9,
      198.9,
      408.1
    ],
    "font_size": 12.0,
    "font_name": "FreeSans",
    "label": "BODY"
  },
  {
    "pdf_id": "670",
    "page_number": 1,
    "block_id": "670_p1_b016",
    "text": "Given that FDA failed to identify a public health basis for why this lengthy proposal was",
    "bbox": [
      42.8,
      448.9,
      503.7,
      468.1
    ],
    "font_size": 12.0,
    "font_name": "FreeSans",
    "label": "BODY"
  },
  {
    "pdf_id": "670",
    "page_number": 1,
    "block_id": "670_p1_b017",
    "text": "necessary at this point in time, the letter’s authors ask FDA to answer questions justifying the",
    "bbox": [
      42.8,
      463.9,
      535.7,
      483.1
    ],
    "font_size": 12.0,
    "font_name": "FreeSans",
    "label": "BODY"
  },
  {
    "pdf_id": "670",
    "page_number": 1,
    "block_id": "670_p1_b018",
    "text": "expenditure of the agency’s limited resources on this effort.",
    "bbox": [
      42.8,
      478.9,
      356.3,
      498.1
    ],
    "font_size": 12.0,
    "font_name": "FreeSans",
    "label": "BODY"
  },
  {
    "pdf_id": "670",
    "page_number": 1,
    "block_id": "670_p1_b019",
    "text": "Documents and Links",
    "bbox": [
      42.8,
      508.7,
      182.0,
      528.1
    ],
    "font_size": 12.0,
    "font_name": "FreeSans",
    "label": "BODY"
  },
  {
    "pdf_id": "670",
    "page_number": 1,
    "block_id": "670_p1_b020",
    "text": "-  Letter to FDA Commissioner von Eschenbach",
    "bbox": [
      45.3,
      538.9,
      328.3,
      558.1
    ],
    "font_size": 12.0,
    "font_name": "FreeSans",
    "label": "BODY"
  },
  {
    "pdf_id": "670",
    "page_number": 1,
    "block_id": "670_p1_b021",
    "text": "-  Press Release: Members of Congress Question FDA Proposal",
    "bbox": [
      45.3,
      553.9,
      416.9,
      573.1
    ],
    "font_size": 12.0,
    "font_name": "FreeSans",
    "label": "BODY"
  },
  {
    "pdf_id": "670",
    "page_number": 1,
    "block_id": "670_p1_b022",
    "text": "1 / 1",
    "bbox": [
      522.3,
      801.8,
      540.1,
      814.6
    ],
    "font_size": 8.0,
    "font_name": "FreeSans",
    "label": "BODY"
  }
]